National Bank of Canada’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-750
Closed -$7.89M 3116
2025
Q4
$7.89M Buy
+750
New +$70.4K 0.01% 770
2023
Q4
Sell
-5,152
Closed -$52.8M 2826
2023
Q3
$52.8M Buy
+5,152
New +$555K 0.08% 220
2022
Q3
Sell
-5,500
Closed -$50.1M 2810
2022
Q2
$50.1M Buy
+5,500
New +$488K 0.23% 105

Other funds holding MRK

National Bank of Canada's MRK Position: Q2 2026 in Review

National Bank of Canada increased its Merck (MRK) stake by 24% in Q2 2026, buying an estimated $55.3M and bringing the position to 2,433,801 shares worth $313M. The position accounts for 0.22% of the portfolio, ranked #88.

National Bank of Canada first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $457M in Q4 2024. 3,021 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • National Bank of Canada held 2,433,801 shares of Merck worth $313M as of Q2 2026.
  • National Bank of Canada bought 472,411 Merck shares in Q2 2026, an estimated $55.3M.
  • Merck made up 0.22% of National Bank of Canada's portfolio in Q2 2026, its #88 holding.
  • National Bank of Canada first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Merck position peaked at $457M in Q4 2024.
  • 3,021 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.